Truist Securities Reiterates Buy Rating, $95 PT on Merck (MRK) Following Earnings
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $95.00 price target on Merck (NYSE: MRK), following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
